Endomix is a biotechnology startup founded in 2021 with the slogan, "Pioneering the Future of Preventive Medicine with Advanced Biotechnology and Clinical Expertise." The company specializes in biotechnology, clinical trials, health diagnostics, and pharmaceuticals, aiming to develop and market technologies that aid in disease prevention. Endomix's offerings include conducting clinical trials and delivering health diagnostic solutions, as well as working on pharmaceutical products that support preventive healthcare. The company received a Non Equity Assistance investment from the TIPS Program on 01 September 2020.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Non Equity Assistance | Unknown | 1 | TIPS Program | 01 Sep 2020 |
No recent news or press coverage available for Endomix.